Last updated 8/11/22
This page lists the most relevant information we can find on COVID-19 relevant to people with MSK conditions. We update this page as new information becomes available. It includes information for professionals, patients, parents and guidance for Wales and Scotland.
Six key resources for MSK.
Latest advice for England.
Good communication with patients whose planned care has been disrupted by COVID-19.
Guidance on those eligible for free lateral flow testing in England after 1 April
Covid-19 community based treatments
Access community-based treatments for coronavirus (COVID-19) updated 6 September 2022
How to access treatments and prescription charges
COVID-19 Therapeutics Clinical Review Panel will determine which at-risk patient cohorts could be eligible for COVID-19 therapies. Information on membership, terms of reference and how to submit.
First report of the panel on Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs. These recommendations will be implemented from 13 June.
Information about neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19. Available for those at the highest risk from COVID-19. From 10/2/22 lateral flow test positive is sufficient. No PCR required.
Interim clinical commissioning policy (Scroll down for most recent version – effective from 13 June.)
Community based treatments for those at highest risk and ‘PANORAMIC’ national study to review the effectiveness of antivirals in a wider at risk patient cohort.
The MELODY study is recruiting people who are immunosuppressed to measure their COVID-19 antibody response following at least 3 vaccinations.
Information on vaccination
Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians (Version 12, 12 September 2022)
JCVI advice for vaccinating 5 to 11-year-olds (updated 16/2/22)
JCVI advice on third primary dose vaccination for severely immunosuppressed (1/9/21)
Letter to GP practices and PCNs (30 September)
Difference between boosters and third primary doses
NHS information for the public on vaccination:
Latest Information and Advice from UK Paediatric Rheumatologists and Ophthalmologists for families re Covid 19 Vaccine (04/08/21)
BSR information on vaccination:
General Chiropractic Council statement on the vaccine:
Information for people with MSK conditions
National Rheumatoid Arthritis Society
Scleroderma & Raynaud’s UK
NHS response to COVID-19
National call: Next steps for the NHS COVID-19 vaccine deployment (13/12/21)
Preparing the NHS for the potential impact of the Omicron variant and other winter pressures (13/12/21)
Community services prioritisation framework to aid local decision making about service and staff prioritisation until 1 March 2022. (11/01/2022)
Long COVID NHS plan for 2021/22
NHSE Speciality guides including:
Most specialty guides for MSK are no longer published on the NHSE website.
COVID-19 rapid guideline: children and young people who are immunocompromised
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services
Clinical Validation of Surgical Waiting Lists: framework and support tools
NICE Covid-19 rapid guidance: arranging planned care in hospitals and diagnostic services (26/7/20)
British Orthopaedic Association and Specialist Society Position paper on caring for patients awaiting surgery
Management of patients with musculoskeletal and rheumatic conditions who: are on corticosteroids; require initiation of oral/IV corticosteroids; require a corticosteroid injection (20/11/20)
- Denosumab (Prolia) treatment and the COVID-19 pandemic
- Toolkit: DXA restoration of service
- Guidance: Secondary fracture prevention for inpatients during COVID-19 pandemic
- All on the Royal Osteoporosis Society Covid-19 Hub
Announcement about the end of the shielding (clinically extremely vulnerable) list in England (15/09/21)
Community MSK services
Restoration of community health services updated 18 September 2020 and COVID-19 restoration of community health services for children and young
people: second phase of NHS response updated 31 July 2020.
The Stanford Hall consensus statement for post-COVID-19 rehabilitation
Guidance from the CSP on implementing remote consultations
COVID-19 – talking to children and families about returning to school: guiding principles
Guidance on infection prevention and control for COVID-19 updated 24/11/21
A risk calculator for rheumatology patients to assess their risk and whether you should be taking extra care with COVID precautions.
FAQs for patients on resuming surgical services
Many patient organisations have helplines and web-based information.
Arthritis Action: https://www.arthritisaction.org.uk/covid-19-advice/
Fibromyalgia UK: http://www.fmauk.org/coronavirus
Hypermobility Syndromes Association: https://www.hypermobility.org/news/covid19-resources
Lupus UK: https://www.lupusuk.org.uk/coronavirus/
National Axial Spondyloarthritis Society (NASS): https://nass.co.uk/managing-my-as/covid19-coronavirus/
National Rheumatoid Arthritis Society (NRAS): https://www.nras.org.uk/coronavirus (info page);
and Here For You, a new service that allows you to arrange a callback with someone with RA who understands you: https://www.nras.org.uk/here-for-you
Psoriasis Association: https://www.psoriasis-association.org.uk/psoriasis-and-treatments/covid-19-information
Royal Osteoporosis Society: https://theros.org.uk/information-and-support/coronavirus-and-osteoporosis
Scleroderma & Raynaud’s UK (SRUK): https://www.sruk.co.uk/find-support/coronavirus/
From SPARN (Scottish Paediatric and Adolescent Rheumatology Network)
CCCA Kids with Arthritis incorporating JIA Matters facebook group
Great Ormond Street Hospital advice for parents of vulnerable children and young people – useful practical advice on shielding for a child.
Resources for young people – specifically about shielding and social distancing and developed with input of children/young people.
Guidance for professionals (nothing MSK specific)
Children and young people to be removed from shielding list (25/08/21)
COVID-19 High risk shielded patient list identification methodology (note different methodology for rheumatology from England and guidance below contains more up to date list)
Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19). (updated 11 June 2021). Shielding in Wales is paused.
https://gov.wales/get-coronavirus-support-extremely-vulnerable-person – contact your local authority
Guidance for healthcare professionals
Information for people at highest risk (updated 23/12/21)
Information for Northern Ireland